BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29631636)

  • 1. Epidemiology of Sanfilippo syndrome: results of a systematic literature review.
    Zelei T; Csetneki K; Vokó Z; Siffel C
    Orphanet J Rare Dis; 2018 Apr; 13(1):53. PubMed ID: 29631636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global epidemiology of mucopolysaccharidosis type III (Sanfilippo syndrome): an updated systematic review and meta-analysis.
    Kong W; Wu S; Zhang J; Lu C; Ding Y; Meng Y
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1225-1235. PubMed ID: 34271605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome.
    Scott HS; Blanch L; Guo XH; Freeman C; Orsborn A; Baker E; Sutherland GR; Morris CP; Hopwood JJ
    Nat Genet; 1995 Dec; 11(4):465-7. PubMed ID: 7493035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sanfilippo syndrome: Overall review.
    Andrade F; Aldámiz-Echevarría L; Llarena M; Couce ML
    Pediatr Int; 2015 Jun; 57(3):331-8. PubMed ID: 25851924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of anesthesia for children with Mucopolysaccharidosis Type III (Sanfilippo syndrome): a review of 86 anesthetics.
    Cohen MA; Stuart GM
    Paediatr Anaesth; 2017 Apr; 27(4):363-369. PubMed ID: 28098417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptoms of Autism Spectrum Disorder (ASD) in Individuals with Mucopolysaccharide Disease Type III (Sanfilippo Syndrome): A Systematic Review.
    Wolfenden C; Wittkowski A; Hare DJ
    J Autism Dev Disord; 2017 Nov; 47(11):3620-3633. PubMed ID: 28856504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucopolysaccharidosis III in Mainland China: natural history, clinical and molecular characteristics of 34 patients.
    Kong W; Meng Y; Zou L; Yang G; Wang J; Shi X
    J Pediatr Endocrinol Metab; 2020 May; 33(6):793-802. PubMed ID: 32447333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical diagnosis of Sanfilippo disorder types A and B.
    Nosier SS; El Nakeeb SMS; Ibrahim MM; El-Gammal M; Fateen EM
    J Genet Eng Biotechnol; 2023 Nov; 21(1):112. PubMed ID: 37947910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outlet type of interventricular septal defect in SanFilippo type-B syndrome.
    Kourouklis S; Chatzis D; Skafida M; Liagkas K; Paradellis G; Kyriakides Z
    Int J Cardiol; 2007 Nov; 122(2):e4-5. PubMed ID: 17234286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, biochemical, and molecular characterization of mucopolysaccharidosis type III in 34 Egyptian patients.
    Almenabawy N; Ramadan M; Kamel M; Mahmoud IG; Amer F; Shaheen Y; Elnaggar W; Selim L
    Am J Med Genet A; 2023 Sep; 191(9):2354-2363. PubMed ID: 37596900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of Sanfilippo syndrome in Spain.
    Delgadillo V; O'Callaghan Mdel M; Gort L; Coll MJ; Pineda M
    Orphanet J Rare Dis; 2013 Dec; 8():189. PubMed ID: 24314109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sanfilippo syndrome in Turkey: Identification of novel mutations in subtypes A and B.
    Emre S; Terzioglu M; Tokatli A; Coskun T; Ozalp I; Weber B; Hopwood JJ
    Hum Mutat; 2002 Feb; 19(2):184-5. PubMed ID: 11793481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth charts for patients with Sanfilippo syndrome (Mucopolysaccharidosis type III).
    Muschol NM; Pape D; Kossow K; Ullrich K; Arash-Kaps L; Hennermann JB; Stücker R; Breyer SR
    Orphanet J Rare Dis; 2019 May; 14(1):93. PubMed ID: 31046785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality in patients with Sanfilippo syndrome.
    Lavery C; Hendriksz CJ; Jones SA
    Orphanet J Rare Dis; 2017 Oct; 12(1):168. PubMed ID: 29061114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sanfilippo Syndrome].
    Osipova LA; Kuzenkova LM; Namazova-Baranova LS; Gevorkyan AK; Podkletnova TV; Vashakmadze ND
    Vestn Ross Akad Med Nauk; 2015; (4):419-27. PubMed ID: 26710524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of mucopolysaccharidoses.
    Khan SA; Peracha H; Ballhausen D; Wiesbauer A; Rohrbach M; Gautschi M; Mason RW; Giugliani R; Suzuki Y; Orii KE; Orii T; Tomatsu S
    Mol Genet Metab; 2017 Jul; 121(3):227-240. PubMed ID: 28595941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Musculoskeletal manifestations of Sanfilippo Syndrome (mucopolysaccharidosis type III).
    White KK; Karol LA; White DR; Hale S
    J Pediatr Orthop; 2011; 31(5):594-8. PubMed ID: 21654471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sanfilippo syndrome: causes, consequences, and treatments.
    Fedele AO
    Appl Clin Genet; 2015; 8():269-81. PubMed ID: 26648750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update of treatment for mucopolysaccharidosis type III (sanfilippo syndrome).
    Kong W; Yao Y; Zhang J; Lu C; Ding Y; Meng Y
    Eur J Pharmacol; 2020 Dec; 888():173562. PubMed ID: 32949598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in gene expression patterns, revealed by RNA-seq analysis, between various Sanfilippo and Morquio disease subtypes.
    Wiśniewska K; Gaffke L; Krzelowska K; Węgrzyn G; Pierzynowska K
    Gene; 2022 Feb; 812():146090. PubMed ID: 34896230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.